NFKB1 and infection: In addition, one of the strategies that STM uses to evade the immune response and to favor its infection is the inhibition of the transduction pathways of NF-κB by the effector molecule SpvB from the pathogenicity island 2 type III secretion system (T3SS-2) (18).